Faro Molecular, Inc.
Developer of a next-generation, highly multiplexed molecular analysis platform that integrates self-contained fluid handling, real-time PCR and DNA melting analysis. The platform is described as automating affinity capture, multiplex PCR and melting curve analysis to quantify epigenetic markers for research and diagnostic applications, with emphasis on rapid time-to-result and high target multiplexing.
Industries
N/A
Products
Highly multiplexed molecular analysis platform
A next-generation platform that automates affinity capture, multiplex PCR and DNA melting analysis in a self-contained format designed to analyze hundreds of targets per sample.
Highly multiplexed molecular analysis platform
A next-generation platform that automates affinity capture, multiplex PCR and DNA melting analysis in a self-contained format designed to analyze hundreds of targets per sample.
Services
Platform development for biomedical and diagnostic applications
Development of an integrated, automated platform combining fluid handling, multiplex PCR and melting analysis for research and diagnostic use.
Platform development for biomedical and diagnostic applications
Development of an integrated, automated platform combining fluid handling, multiplex PCR and melting analysis for research and diagnostic use.
Expertise Areas
- Molecular diagnostics
- High-plex assay development
- Assay automation and workflow integration
- Epigenetic biomarker quantification
Key Technologies
- Real-time PCR (qPCR)
- DNA melting curve analysis
- High-multiplex nucleic acid assays
- Automated fluid handling